Overview
- Authors:
-
-
Dietrich Schmähl
-
Institut für Toxikologie und Chemotherapie, Deutsches Krebsforschungszentrum, Heidelberg, Deutschland
-
Carlos Thomas
-
Pathologisches Institut, Universität Freiburg, Freiburg i. Br., Federal Republic of Germany
-
Rolf Auer
-
Pathologisches Institut, Universität Freiburg, Freiburg i. Br., Federal Republic of Germany
Access this book
Other ways to access
Table of contents (3 chapters)
-
-
- Dietrich Schmähl, Carlos Thomas, Rolf Auer
Pages 1-3
-
- Dietrich Schmähl, Carlos Thomas, Rolf Auer
Pages 4-62
-
- Dietrich Schmähl, Carlos Thomas, Rolf Auer
Pages 63-100
-
Back Matter
Pages 101-122
About this book
The purpose of this book, which is written mainly for pharmacothera pists, is to draw the physician's attentions, through specific examples, to iatrogenic (i.e., diagnostically or therapeutically induced) carcino genesis. The book is not intended, however, to arouse public concern. It has been known for some time that each therapeutic measure has a risk-benefit ratio, the estimation of which requires an understanding of carcinogenic side-effects. The number of iatrogenic tumors published so far is not large; however, we assume that there are a number of cases that have not been registered. In the past it was not generally recognized that medical treatment might involve carcinogenic risks; moreover, various therapeutic measures are often used simultaneously so that it may be difficult to trace the cause of tumor formation to a specific agent. Animal experiments and clinical observations during the past few years have contributed to our knowledge of the possible hazards of drugs. We have compiled the most important literature on the subject without, however, attempting completion. The present book may help the pharmacotherapist balance the benefit of a drug against its potential risk, and is thus consistent with the medical principle of nil nocere. We thank Mrs. M. Gomille (Institut fur Toxikologie und Chemothera pie, Deutsches Krebsforschungszentrum, Heidelberg) for her help in the preparation of the manuscript.
Authors and Affiliations
-
Institut für Toxikologie und Chemotherapie, Deutsches Krebsforschungszentrum, Heidelberg, Deutschland
Dietrich Schmähl
-
Pathologisches Institut, Universität Freiburg, Freiburg i. Br., Federal Republic of Germany
Carlos Thomas,
Rolf Auer